Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: PROIMMUNE, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-09-20 to 2023-09-25
Current total value of award: $53487
Description: A COMPARISON OF CAS9 PROTEINS DERIVED FROM DIFFERENT ORGANISMS IN A DENDRITIC CELL - T CELL (DC-T) CELL PROLIFERATION ASSAY AS WELL AS AN ANTIGEN PRESENTING ASSAY (ALSO CALLED A MHC ASSOCIATED PEPTIDE PROTEOMICS (MAPPS) ASSAY).